Parkinson’s Foundation Welcomes Paul H. Nathan to Board of Directors
(May 3, 2017-New York, NY and Miami, FL) – The Parkinson’s Foundation is pleased to announce the election of financial services executive Paul H. Nathan of San Francisco, CA, to its Board of Directors. The appointment was announced following a meeting of the board on April 27.
Mr. Nathan serves as director of multiple international hedge funds as well as a Director of JTC (Cayman) Ltd., formerly the Julius Baer Bank and Trust (Cayman) Ltd., and is President and owner of Ledex Consulting Corporation. He has more than 30 years of experience with trading, product development, risk management, asset allocation and operations. He also brings a personal connection to Parkinson’s to bear on his new role.
“My involvement is driven by a very personal experience of watching my father fight Parkinson’s disease,” said Mr. Nathan. “I am excited to join the board at this time, as the Parkinson’s Foundation kicks off a new era that promises to transform research and care and improve lives.”
Mr. Nathan is philanthropically active as President and CFO of his family foundation, the Atmos Foundation. He also serves as board member and President Elect of the Claremont McKenna College Alumni Association, board member of the Keck Center for International and Strategic Studies, and board member of the Financial Economics Institute.
“Mr. Nathan brings critical business and philanthropic experience that will advance the Parkinson’s Foundation’s mission to serve the 10 million people worldwide living with this disease,” added John W. Kozyak, Esq., Chairman of the Board, Parkinson’s Foundation.
About the Parkinson's Foundation
The Parkinson's Foundation is working toward a world without Parkinson's disease. Formed by the merger of National Parkinson Foundation (NPF) and the Parkinson's Disease Foundation (PDF) in August 2016, the mission of the Parkinson's Foundation is to invest in promising scientific research that will end Parkinson's disease and improve the lives of people with Parkinson's, and their families, through improved treatments, support and the best care. For more information, visit www.parkinson.org or www.pdf.org, or call (800) 4PD-INFO (473-4636) or (800) 457-6676.
About Parkinson's Disease (PD)
Affecting an estimated one million Americans and ten million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.